# A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia

> **NCT00764374** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 412 (actual)

## Conditions studied

- Dyspepsia
- Functional Dyspepsia

## Interventions

- **DRUG:** YM443

## Key facts

- **NCT ID:** NCT00764374
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 412 (ACTUAL)
- **Last updated:** 2014-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00764374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00764374, "A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00764374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*